697 related articles for article (PubMed ID: 7540445)
41. [Changes in blood coagulation in treatment with hydroxyethyl starch].
Sefrin P; Rauch S; Zieglmeyer C
Anaesthesiol Reanim; 1998; 23(6):149-56. PubMed ID: 10036794
[TBL] [Abstract][Full Text] [Related]
42. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
[TBL] [Abstract][Full Text] [Related]
43. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4.
Hanart C; Khalife M; De Villé A; Otte F; De Hert S; Van der Linden P
Crit Care Med; 2009 Feb; 37(2):696-701. PubMed ID: 19114887
[TBL] [Abstract][Full Text] [Related]
44. [Effects of angiotensin II receptor antagonist on intestinal mucosal oxygenation during canine isovolemic hemodilution with hydroxyethyl starch].
Hayashi K
Masui; 2003 Jun; 52(6):603-10. PubMed ID: 12854474
[TBL] [Abstract][Full Text] [Related]
45. [Pharmacokinetic studies of blood protein binding of bupivacaine following acute preoperative hemodilution].
Bachmann-M B; Biscoping J; Violka T; Schürg R; Hempelmann G
Reg Anaesth; 1991 Mar; 14(2):32-7. PubMed ID: 2034826
[TBL] [Abstract][Full Text] [Related]
46. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis.
Fernández J; Monteagudo J; Bargallo X; Jiménez W; Bosch J; Arroyo V; Navasa M
Hepatology; 2005 Sep; 42(3):627-34. PubMed ID: 16108036
[TBL] [Abstract][Full Text] [Related]
47. Cerebral blood flow, blood volume, and brain tissue hematocrit during isovolemic hemodilution with hetastarch in rats.
Todd MM; Weeks JB; Warner DS
Am J Physiol; 1992 Jul; 263(1 Pt 2):H75-82. PubMed ID: 1379006
[TBL] [Abstract][Full Text] [Related]
48. [Changes in blood volume during acute normovolemic hemodilution with 5% albumin or 6% hydroxyethylstarch and intraoperative retransfusion].
Rehm M; Orth VH; Kreimeier U; Thiel M; Mayer S; Brechtelsbauer H; Finsterer U
Anaesthesist; 2001 Aug; 50(8):569-79. PubMed ID: 11556167
[TBL] [Abstract][Full Text] [Related]
49. Hypervolumetric hemodilution with HES 100/0.5 10% in patients with peripheral arterial occlusive disease (Fontaine, stage II): an open clinical and pharmacological phase IV study.
Koscielny J; Latza R; Pruss A; Kiesewetter H; Jung F; Meier C; Schimetta W
Clin Hemorheol Microcirc; 2000; 22(1):53-65. PubMed ID: 10711822
[TBL] [Abstract][Full Text] [Related]
50. Effects of chronic exercise on blood volume expansion and hematologic indices during pregnancy.
Pivarnik JM; Mauer MB; Ayres NA; Kirshon B; Dildy GA; Cotton DB
Obstet Gynecol; 1994 Feb; 83(2):265-9. PubMed ID: 8290192
[TBL] [Abstract][Full Text] [Related]
51. Extreme, progressive isovolemic hemodilution with 5% human albumin, PentaLyte, or Hextend does not cause hepatic ischemia or histologic injury in rabbits.
Nielsen VG; Baird MS; Brix AE; Matalon S
Anesthesiology; 1999 May; 90(5):1428-35. PubMed ID: 10319792
[TBL] [Abstract][Full Text] [Related]
52. Isovolemic hemodilution with a bovine hemoglobin-based oxygen carrier: effects on hemodynamics and oxygen transport in comparison with a nonoxygen-carrying volume substitute.
Krieter H; Hagen G; Waschke KF; Köhler A; Wenneis B; Brückner UB; van Ackern K
J Cardiothorac Vasc Anesth; 1997 Feb; 11(1):3-9. PubMed ID: 9058211
[TBL] [Abstract][Full Text] [Related]
53. A computer model comparing normovolemic hemodilution, hypervolemic hemodilution, and neither on intraoperative blood loss and final hematocrit.
Engoren M
Am J Anesthesiol; 1995; 22(5):229-34. PubMed ID: 10159678
[TBL] [Abstract][Full Text] [Related]
54. Hemospan improves outcome in a model of perioperative hemodilution and blood loss in the rat: comparison with hydroxyethyl starch.
Young MA; Lohman J; Malavalli A; Vandegriff KD; Winslow RM
J Cardiothorac Vasc Anesth; 2009 Jun; 23(3):339-47. PubMed ID: 18948027
[TBL] [Abstract][Full Text] [Related]
55. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
Treib J; Haass A; Pindur G; Seyfert UT; Treib W; Grauer MT; Jung F; Wenzel E; Schimrigk K
Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
[TBL] [Abstract][Full Text] [Related]
56. Relative blood volume changes underestimate total blood volume changes during hemodialysis.
Dasselaar JJ; Lub-de Hooge MN; Pruim J; Nijnuis H; Wiersum A; de Jong PE; Huisman RM; Franssen CF
Clin J Am Soc Nephrol; 2007 Jul; 2(4):669-74. PubMed ID: 17699480
[TBL] [Abstract][Full Text] [Related]
57. [Hydroxyethyl starch as plasma substitute: experiments in isovolamic haemodilution (author's transl)].
Jesch F; Klövekorn WP; Sunder-Plassmann L; Seifert J; Messmer K
Anaesthesist; 1975 May; 24(5):202-9. PubMed ID: 56900
[TBL] [Abstract][Full Text] [Related]
58. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
[TBL] [Abstract][Full Text] [Related]
59. Measurement of red-cell and plasma volumes.
Bernard PJ
Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):155-7. PubMed ID: 8036132
[TBL] [Abstract][Full Text] [Related]
60. Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy.
Rehm M; Haller M; Orth V; Kreimeier U; Jacob M; Dressel H; Mayer S; Brechtelsbauer H; Finsterer U
Anesthesiology; 2001 Oct; 95(4):849-56. PubMed ID: 11605923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
